Lyme Disease Investigational Vaccine Study

Now Enrolling in Omaha and Providence

Now Enrolling

About this research study

Affecting more than 30,000 people every year in the U.S., Lyme disease (LD) is spread through tick bites. LD can cause a wide range of syndromes, from fever and joint and muscle pain, to arthritis, inflammation of the heart or brain, and other neurological issues if left untreated.

Velocity is currently enrolling people ages 18-70 for a study of an investigational Lyme disease vaccine.

Eligible participants...

  • Must be ages 18 to 70 years
  • Must NOT have received a tick bite within the past 4 weeks
  • Must NOT been diagnosed with and treated for Lyme disease within the past 3 months
  • Will receive compensation for study-related time

For more information, complete the form on this page. After you submit your information, a Velocity enrollment specialist will call you to talk about the study. There is no obligation to participate — you can decide if the study is right for you.

Enter your info

Study Locations

Omaha, Nebraska • Velocity Clinical Research

3319 N. 107th St., Omaha, NE 68134
Phone: (513) 381-3320

Providence (East Greenwich), Rhode Island • Velocity Clinical Research

1598 South County Trail, Suite 204, East Greenwich, RI 02818
Phone: (401) 739-9350
Row concave Shape Decorative svg added to top

©2023 Velocity Clinical Research | All Rights Reserved | Privacy Policy